en
Scientific article
English

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells

Publication date2010
Abstract

Immune-mediated diseases of the CNS, such as multiple sclerosis and its animal model, experimental autoimmune encephalitis (EAE), are characterized by the activation of antigen-presenting cells and the infiltration of autoreactive lymphocytes within the CNS, leading to demyelination, axonal damage, and neurological deficits. Hepatocyte growth factor (HGF) is a pleiotropic factor known for both neuronal and oligodendrocytic protective properties. Here, we assess the effect of a selective overexpression of HGF by neurons in the CNS of C57BL/6 mice carrying an HGF transgene (HGF-Tg mice). EAE induced either by immunization with myelin oligodendrocyte glycoprotein peptide or by adoptive transfer of T cells was inhibited in HGF-Tg mice. Notably, the level of inflammatory cells infiltrating the CNS decreased, except for CD25(+)Foxp3(+) regulatory T (T(reg)) cells, which increased. A strong T-helper cell type 2 cytokine bias was observed: IFN-gamma and IL-12p70 decreased in the spinal cord of HGF-Tg mice, whereas IL-4 and IL-10 increased. Antigen-specific response assays showed that HGF is a potent immunomodulatory factor that inhibits dendritic cell (DC) function along with differentiation of IL-10-producing T(reg) cells, a decrease in IL-17-producing T cells, and down-regulation of surface markers of T-cell activation. These effects were reversed fully when DC were pretreated with anti-cMet (HGF receptor) antibodies. Our results suggest that, by combining both potentially neuroprotective and immunomodulatory effects, HGF is a promising candidate for the development of new treatments for immune-mediated demyelinating diseases associated with neurodegeneration such as multiple sclerosis.

Keywords
  • Animals
  • Antigen Presentation
  • Cell Proliferation
  • Cytokines/biosynthesis/immunology
  • Dendritic Cells/immunology
  • Encephalomyelitis, Autoimmune, Experimental/genetics/immunology
  • Forkhead Transcription Factors/immunology
  • Hepatocyte Growth Factor/genetics/immunology
  • Immune Tolerance
  • Interleukin-2 Receptor alpha Subunit/immunology
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Spleen/cytology/immunology
  • T-Lymphocytes, Regulatory/cytology/immunology
  • Th2 Cells/immunology
Citation (ISO format)
BENKHOUCHA, Mahdia et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. In: Proceedings of the National Academy of Sciences of the United States of America, 2010, vol. 107, n° 14, p. 6424–6429. doi: 10.1073/pnas.0912437107
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0027-8424
628views
0downloads

Technical informations

Creation11/13/2013 9:24:00 AM
First validation11/13/2013 9:24:00 AM
Update time03/14/2023 8:36:25 PM
Status update03/14/2023 8:36:25 PM
Last indexation01/16/2024 8:08:06 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack